Baicalein mediates protection against Staphylococcus aureus-induced pneumonia by inhibiting the coagulase activity of vWbp

Biochem Pharmacol. 2020 Aug;178:114024. doi: 10.1016/j.bcp.2020.114024. Epub 2020 May 13.

Abstract

The emergence and spread of multidrug-resistant Staphylococcus aureus (S. aureus) necessitate the research on therapeutic tactics which are different from classical antibiotics in overcoming resistance andtreatinginfections. In S. aureus, von Willebrand factor-binding protein (vWbp) is one of the key virulence determinants because it mediates not only the activation of thrombin to convert fibrinogen to fibrin, thereby enabling S. aureus to escape from the host immune clearance, but also the adhesion of S. aureus to host cells. Thus, vWbp is regarded as a promising druggable target to treat S. aureus-associated infections. Here we identify that baicalein, a natural compound isolated from the Chinese herb Scutellaria baicalensis, can effectively block the coagulase activity of vWbp without inhibiting the growth of the bacteria. Through thermal shift and fluorescence quenching assays, we demonstrated that baicalein directly binds to vWbp. Molecular dynamics simulations and mutagenesis assays revealed that the Asp-75 and Lys-80 residues are necessary for baicalein binding to vWbp. Importantly, we demonstrated that baicalein treatment attenuates the virulence of S. aureus and protects mice from S. aureus-induced lethal pneumonia. In addition, baicalein can improve the therapeutic effect of penicillin G by 75% in vivo. These findings indicate that baicalein might be developed as a promising therapeutic agent against drug-resistant S. aureus infections.

Keywords: Baicalein; Coagulase activity; Direct inhibitor; Staphylococcus aureus; Von Willebrand factor-binding protein (vWbp).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coagulase / antagonists & inhibitors*
  • Coagulase / metabolism
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Flavanones / pharmacology
  • Flavanones / therapeutic use*
  • Mice
  • Mice, Inbred C57BL
  • Molecular Docking Simulation / methods
  • Pneumonia, Staphylococcal / enzymology
  • Pneumonia, Staphylococcal / prevention & control*
  • Protein Binding
  • Staphylococcal Infections / enzymology
  • Staphylococcal Infections / prevention & control
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / physiology
  • von Willebrand Factor / antagonists & inhibitors*
  • von Willebrand Factor / metabolism

Substances

  • Coagulase
  • Enzyme Inhibitors
  • Flavanones
  • Von Willebrand antigen
  • von Willebrand Factor
  • baicalein